chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A spontaneous, non-serious report of sinus drainage, headache, lethargy, sore throat and cough has been received from a consumer concerning herself, a 45-year-old female patient subsequent to FLUMIST administration. Medical history included penicillin and doxycycline allergies, ear surgery for cholesteatoma of the left ear (3 times), non-smoker and occasional alcohol use. She received FLUMIST last year. Concomitant medications included oral contraceptive (norethindrone and ethinyl estradiol combination). On 25-Sep-2010, the patient received FLUMIST. Prior to receiving FLUMIST, the subject felt that she was "trying to catch a cold" but had not become ill. On 27-Sep-2010, she began to feel "a little under the weather". On 28-Sep-2010, the patient developed a serious headache and lethargy. On the evening of that day, she also developed sinus drainage and a sore throat; she developed a cough on 30-Sep-2010. On 30-Sep-2010, the patient went to see her physician. She was prescribed a phenylephrine, chlorpheniramine and dextromethorphan-containing cough syrup and azithromycin. On 04-Oct-2010, the patient returned to see her physician. She was told to continue her medications and was told that she could take cetirizine at night. On 09-Oct-2010, sinus drainage, headache, lethargy and sore throat were resolved; on 05-Nov-2010 her cough resolved. On 09-Oct-2010, the events of sinus drainage, headache, lethargy, sore throat were resolved; On 05-Nov-2010, cough was resolved. Additional information was received on 09-Nov-2010 and incorporated into the narrative; resolution date for cough was 05-Nov-2010.
Had stiffness in back and legs immediately soreness in arm at the site of the vaccine, one month later soreness was reported to the above number. Several calls since last fall, plum-sized area pinkish above the vaccine.
Case of Shingles. Presentation on right lateral  flank. Rash, blisters, soreness.  Still present  on day 13. Ibuprofen  for pain.
Menveo administered instead of MMR.; This case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 12-month-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMAA677A, expiry date 30th April 2023) for prophylaxis.   On 27th September 2022, the patient received Menveo. On 27th September 2022, unknown after receiving Menveo, the patient experienced wrong vaccine administered. On an unknown date, the outcome of the wrong vaccine administered was unknown.   Additional Information: GSK Receipt Date: 27-SEP-2022 Reporter's Comment: The reporter was medical assistant. The reporter reported that, 12 months old patient was administered a dose of Menveo instead of MMR. The vaccine administration facility was the same as primary reporter. She was in a hurry to be transferred to second line agent and did not provide mailing address information. The reporter consented to follow up. Additional Supportive Information: The reporter reported that, 12 months old patient was administered a dose of Menveo instead of MMR, which led to wrong vaccine administered .
I had what they call Bell's Palsy, a nerve virus, it acts like a stroke, and it happened on the left side. I ended up in the ER and they ran all kinds of tests to make sure it was not a stroke. I do not know what tests they did. They said it could be a reaction to the vaccine. I took therapy for a month because I could not walk straight, and I could not keep my balance. I still have to use a walker and a cane to walk because I have a tendency to fall to the left side. I had to take steroids for a week and then they put me on a nerve pill for pain and headaches.
ALSO RECEIVED FLUZONE HD LOT UJ307AA EX 06-29-2020 IN LEFT DELTOIC
PT STATED HE FELT LIGHT HEADED FOLLOWING VACCINE ADMINISTRATION.  HAD THE PATIENT LAY ON THE FLOOR AND ELEVATE HIS FEET AND APPLIED A COLD COMPRESS TO HIS NECK. HE RECOVERED QUICKLY
About 6 hours after injection, the upper outer arm turned red from shoulder down to just above elbow and was warm to the touch.  2 days after injection, the reaction began subsiding.  3 days after the injection, the soreness in the arm is subsiding and the arm is only red on the outside of the arm just above the elbow.  The patient declined to go see a doctor about the reaction.
Smallpox vaccine on 22 Feb 03, developed headaches & arthralgia on 25 Feb 03.  On 5 Mar 03 had low grade fever and small left facial rash.  Rash expanded and by 8 Mar 03 there is a confluent mild bullous erthematous facial rash in a butterfly distribution.
Client presented with Mom to health dept approximately 24 hours after immunization inoculation with 3 1/2 x 4 inch welt (LA). Client and Mom denied fever, vomiting, diarrhea and hives. Referred client to ER. Called Mom for follow up. ER physician recommended BENADRYL and cold compress. Welt was gone next morning. Physician recommends next doses with BENADRYL.
This was the Moderna Booster (039D21A), originally I was given the Johnson and Johnson Vaccine 3/13/21.  The evening I received the booster I had a slight fever and extreme back pain between the shoulder blades and other muscle aches. The pain in my back was so excruciating I was on the floor for hours.  The next day the pain had resolved completely and no fever. But a few weeks later my lymph nodes in different areas were swollen starting in my right leg then to the collar bone areas then head.  This lasted fora  few weeks.  It was then I made a doctor appointment because during this time red spots appeared in different areas of the body.  When I saw my doctor originally he did not think the spots were a rash, he wanted us to wait and see if they went away.  But the number increased, and the older spots did not go away.  I contacted the doctor and told him and he then prescribed me a medication for a rash, I told him I did not think it was a rash, and since I had an upcoming dermatology appoint we waited to get that doctor's opinion.  She diagnosed the spots as cherry angiomas and said I did not need to worry.  My lymph nodes are no longer swollen, the angiomas are still present.
pt recv & devel a local rxn & swelling @ the inj site;pt was treated w/DPH & recovered as of the date of this report;this is one of three pt from this site;
Patient received 2nd Covid Pfizer vaccine 14 days from the 1st vaccine. Father says patient had rash on waist/hip that resolved in around 7 days
pt recv vax 26JUN95 & 1AUG95 pt devel herpes zoster/shingles, a number of ear infect & febrile convuls;f/u pt MD reported that the pt had devel a zoster rash on rt buttocks & thigh;also exp mild irritability for 1 to 2 days;
approx 75 minutes after vaccination child suffered a seizure lasting approx 5 minutes.  9-1-1 was called, seen at the local emergency room.  Released after approx 3 hours after tests, chest x-ray, CT.    NO Fever at time of seizure.  This is the first seizure this child has ever had, happening within 90 minutes of vaccination
Chest discomfort, tinnitus, heart palpitations, pulse of 140, blood pressure - 155/102.
Patient received first dose of COVID-19 vaccine (Moderna) on 4/13/21. The second dose of COVID-19 vaccine was Pfizer-BioNTech, which was administered on 6/4/21.
Headache, Myalgia & NauseaVomiting Narrative:  dose 2 ha- ha;chills;n/v;fatigue;pain and redness at inj  site
My son said his stomach hurt, and he vomited. Then his face turned red and blotchy. His nose became dark red and swelled. Also, his ears were red, and he started scratching his face and ears, saying they were itchy.
Initial report was received on 16 November 2011 from a health care professional. A 21 year-old female who had a platelet count of 51 on 08 October 2011 had received an intramuscular injection of FLUZONE, lot number UT481AB (site of administration not reported) on 31 October 2011 and seven days later on 07 November 2011 the patient had blood work that revealed a decrease platelet count of 33. The patient had no known allergies. Illness at the time of vaccination, other vaccinations within four weeks of suspect vaccine, other medications and medical history were denied. No further information was available at the time of vaccination. The patient's outcome was unknown. Documents held by sender: none.
Vomit, Nausea, Fever, body Aches, Malaise.
Patient hospitalized within 6 weeks of vaccine. Hospitalized on 2-3-21, 3-17-21, 3-19-21,  3-20-21 and 3-24-21.
Patient had received 1st dose of Pfizer vaccine on 05/21/2021, 6 days later noted lump on clavicle.
first shot i ever got I got sick; bad strain shots were not very effective; Initial information was received on 05-Nov-2020 regarding an unsolicited valid non-serious social media case from a patient child. The case is related case ID 2020SA313237 (case of father).  This case involves a patient of unknown demographics who complained of getting sick after the first shot (illness) and that it was bad strain shots that were not very effective (therapeutic product ineffective) while the patient received INFLUENZA VACCINE.  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided.   Concomitant medications were not reported.   On an unknown date in 2016 (reported about 4 years ago), the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer, batch number and other dosing details were not reported) for prophylactic vaccination.  On an unknown date in 2016, when the patient had received the first ever shot, the patient had got sick (illness) and that it was a bad strain sot which was not very effective (therapeutic product ineffective), (unknown latency) following the administration of INFLUENZA VACCINE.   Details of laboratory data were not reported.  Corrective treatment was not reported.   The event outcome was unknown for sickness and not applicable for therapeutic product ineffective.  There will be no information available on the batch number for this case.
This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. The patient medical history and concurrent conditions were not reported. On 23-FEB-2016, the patient was vaccinated with incorrect stored ROTATEQ (dose, lot number and expiry date were not reported). Concomitant therapy was not reported. It was reported that, temperature was 34F for 18 hours. There was no previous temperature excursion. No adverse effect was reported. This is one of several reports from the same reporter. Additional information has been requested.
PT was complaining of numbness and tingling on Rt arm of vaccination site. fingers became swollen on RT side
Chills 12 h after receipt of vaccine followed by low grade fever (101 F) and body ache with minor headache. Symptoms subsided by the end of the following day. 1st menstrual period post-vaccination was noticeably heavier with more clots than usual.
Rotarix was administered IM; This case was reported by a nurse via call center representative and described the occurrence of inappropriate route of vaccination in a 2-month-old female patient who received Rota (Rotarix lyophilized formulation) (batch number K2FM7, expiry date 4th July 2023) for prophylaxis.   Co-suspect products included rotavirus vaccine oral applicator device (Rotarix Oral Applicator Device) oral applicator for prophylaxis.   On 28th July 2022, the patient received the 1st dose of Rotarix lyophilized formulation (intramuscular) and Rotarix Oral Applicator Device. On 28th July 2022, unknown after receiving Rotarix lyophilized formulation and Rotarix Oral Applicator Device, the patient experienced inappropriate route of vaccination. On an unknown date, the outcome of the inappropriate route of vaccination was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional Information: GSK Receipt Date: 28-JUL-2022 Reporter's Comments: The Rotarix was administered to the patient intramuscularly instead of by mouth. The reporter consented to follow up via postal. Additional Supportive Information: The patient received vaccine intramuscularly instead of by mouth, which led to inappropriate route of vaccination.
This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced can't even sleep in bed because if I roll over on it I wake up because of the pain, and arm still sore like whole upper arm hurts. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from arm still sore like whole upper arm hurts, and can't even sleep in bed because if I roll over on it I wake up because of the pain. This report was non-serious.
red bump from injection  itchy at injection almost passed out at the gym this morning was dizzy and need to sit for a moment on the floor
tiredness; achiness; This case was reported by a consumer via call center representative and described the occurrence of fatigue in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 18th February 2020, the patient received the 2nd dose of Shingrix (intramuscular). In February 2020, less than a week after receiving Shingrix, the patient experienced fatigue and general body pain. On an unknown date, the outcome of the fatigue and general body pain were unknown.   It was unknown if the reporter considered the fatigue and general body pain to be related to Shingrix.  Additional details were received as follows: The case was reported by patient's husband. The patient received second dose of Shingrix on  and experienced tiredness and achiness. The reporter did not consent to follow-up.
Hyperglycemia with polyuria. Peak CBG 300 postprandial first night but fasting CBG still 177 at 48hr
t99-103 x 4 days; numbness of both arms 2 hrs following immun; Seen by MD dx as viral pneumonia to vax; rx w/Kelfex; has had inc difficulty abdominal pain, nausea, vomiting p/eating eggs;
Significant arm pain at the site of the injection; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other and describes the occurrence of VACCINATION SITE PAIN (Significant arm pain at the site of the injection) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Significant arm pain at the site of the injection). At the time of the report, VACCINATION SITE PAIN (Significant arm pain at the site of the injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       no concomitant medication provided. no treatment information provided; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the event, a causal relationship cannot be excluded.
Site: Pain at Injection Site-Mild, Systemic: Confusion-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: feeling of floating in the air per patient account-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Nausea-Mild, Systemic: Shakiness-Mild, Systemic: Visual Changes/Disturbances-Mild, Systemic: Vomiting-Mild, Systemic: Weakness-Mild, Additional Details: pt sudden onset within 2 minute of injection of flu with covid . Rph to administer the epi pen but Parent stop it . Pt was given water after she requested for it. after 15 minutes Rph observed and responsive to question and prompt of rph
Information has been received from a physician concerning an 18 year old male patient who on 14-SEP-1992 was vaccinated with the first dose of MMR II. On 14-OCT-1996, the patient received the second dose of MMR II. Laboratory diagnostic tests were performed on 03-DEC-2009: IgM: 0.23; IgG: 3.63 and serum amylase test: 34. On 03-DEC-2009, the patient was diagnosed. It was reported that on 22-DEC-2009 the patient experienced mumps. The outcome of the patient was not reported. Follow up information has been received regarding the 18 year old male patient who on 21-JAN-2010 (previously reported as 22-DEC-2009) experienced mumps. On 22-JAN-2010, the patient was diagnosed with mumps, the patient had swelling under the right ear and soar throat, the patient developed right parotitis. On 22-JAN-2010 the first blood work was performed, the results were: IgM (<1:10) : <1:10, IgG (>1.10): 5.99 and serum amylase: 49. It was noted that the patient did not receive a third dose of MMR II. It was unknown if the patient experienced orchitis, was exposed to others with mumps and or experienced any sequelae. At the time of the report, the patient's outcome was unknown. This is one of several reports from the same source. Additional information is not expected.
no additional AE; administered dose of GARDASIL was incomplete / there was still liquid in the syringe after administrating the vaccine; This spontaneous report was received from a registered nurse referring to a patient of unknown age. No information was provided regarding the patient's medical history, concurrent conditions, past drug history or concomitant medications.  On 09-DEC-2019 and 15-JUL-2020, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) dose 1 an 2 respectively (dose, route and site of administration, lot number and expiration date were not reported).  On 06-OCT-2020, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) pre-filled syringe, 0.5ml, dose 3 for prophylaxis  (route and site of administration, lot number and expiration date were not reported).  The nurse stated the patient did not receive the full dose, she noticed there was still liquid in the syringe after administrating the vaccine to the patient, so it was incomplete (underdose).  The patient experienced no adverse event.    The outcome of underdose was unknown.   The nurse inquired the validity of the administered dose of  hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9). combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF);   deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
paralyzed from neck down; fever; an infection related to catheter; Initial information was received on 05-Oct-2020 regarding an unsolicited valid serious case from a consumer/non-health care professional (caregiver).  This case involves an 89 years old male patient who was paralyzed from his neck down (paralysis), had a fever (pyrexia) and died due to an infection related to catheter (device related infection), while he received INFLUENZA VACCINE.  Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.   On an unknown date in Dec-2007, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) once via an unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient was paralyzed from neck down (paralysis) 5 hours following the administration of INFLUENZA VACCINE. He was taken to the hospital for 2 days and got back the use of everything but his legs, and then the hospital discharged him to a rehabilitation center that was more reactive, than preventative. The event paralysis was assessed as medically significant.  Case details: The family (2 nurses in the family) felt that the patient had Guillen's Barre, however this was never officially diagnosed. The patient died in the rehabilitation center within a week due to an infection related to his catheter (device related infection) even though he was not running a fever. At the very end he ran a fever (pyrexia, non-serious event), but they did not put him on the appropriate antibiotics. No autopsy was completed.  The event device related infection was assessed as medically significant and led to death.  No laboratory data was provided.   It was not reported if the patient received a corrective treatment.  At the time of report, the outcome of paralysis and pyrexia was unknown while the event device related infection was fatal.  The cause of death was reported as device related infection.  Information on lot number was requested.; Sender's Comments: This case involves an 89 years old male patient who had paralysis, pyrexia and died due to device related infection after vaccination with INFLUENZA VACCINE (produced by unknown manufacturer). The time to onset is compatible. Additional information regarding medical history, condition at the time of vaccination, concomitant medications, lab /radiological investigation excluding other etiologies and detail autopsy report would be needed for complete assessment of the case. Based upon the reported information, the role of vaccine cannot be assessed.; Reported Cause(s) of Death: an infection related to catheter
Diffuse hives and pruiritis- onset 2hrs after vaccination. Duration, 48hrs Tx'd with Benadryl and Hydrocortisone cream with good results.
When I caught COVID-19 I had a minor sore throat, nasal congestion, and a minor cough. I am a nurse practitioner, and I thought I should take a COVID-19 test since I am around patients. The test had came back positive. My doctor prescribed paxlovid. I took the paxlovid for 2 days, and then it messed up my stomach and gave me a metallic taste in my mouth so my doctor told me to stop taking it.
After 7 days I got the second shot of the vaccine, still have some back lower pains going on and off, a little joint pain, a little headache, some little pain in my legs some times and I feel like FLU symptoms, my blood pressure is fine 130/80, blood sugar average 180.  Besides all my regular medication, I am taking Tylenol twice a day two pills and after taking the Tylenol I feel better.
Moderate headache; Mild fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 39-years-old female patient received bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, Lot Number: El3247) solution for injection, dose 1 via an unspecified route of administration, administered in Arm Left on 01Mar2021 09:30 as 1st dose, single for covid-19 immunisation. The patient's medical history not reported. Concomitant medications included cetirizine hydrochloride, pseudoephedrine hydrochloride (ZYRTEC-D), ibuprofen and minerals nos, quercetin,thioctic acid, vitamins nos (EMERGEN-C). On 01Mar2021 11:30 am, patient experience moderate headache and mild fatigue. Patient did not received treatment for the adverse event. The patient was not diagnosed with covid-19 prior to vaccination and since the vaccination, patient had not been tested for covid-19. She is not pregnant at the time of vaccination. She did not have other medical history and allergies to medications, food, or other products. She did not receive any other vaccines within 4 weeks prior to the covid vaccine. The start date of the symptoms was 01Mar2021 and ended the afternoon of 02Mar2021. The outcome of the event was recovered on 02Mar2021.   No follow-up are needed. No further information is expected.
15OCT96 lt upper arm soreness, jittery, h/a, nausea, joints ache, muscle aches devel shortly p/inj;cont w/sx on 16OCT96, MD notified, no tx ordered;